Cargando…
The staging of sepsis: understanding heterogeneity in treatment efficacy
Human sepsis is an intrinsically complex disease. Populations of patients enrolled into clinical trials of novel sepsis therapies are notoriously heterogeneous with respect to the inciting cause of their disease, the co-morbid conditions that define its course, and the acute severity of their initia...
Autor principal: | Marshall, John C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1414009/ https://www.ncbi.nlm.nih.gov/pubmed/16356249 http://dx.doi.org/10.1186/cc3907 |
Ejemplares similares
-
The International Sepsis Forum's controversies in sepsis: how will sepsis be treated in 2051?
por: Marshall, John C
Publicado: (2002) -
Understanding genetics of sepsis: will new technology help?
por: Yende, Sachin, et al.
Publicado: (2009) -
Surviving sepsis: a guide to the guidelines
por: Vincent, Jean-Louis, et al.
Publicado: (2008) -
The liver in sepsis: shedding light on the cellular basis of hepatocyte dysfunction
por: Marshall, John C
Publicado: (2013) -
The epidemiology of sepsis: questioning our understanding of the role of race
por: Valley, Thomas S., et al.
Publicado: (2015)